Meribel Pharma Solutions is a mid-sized CDMO, headquartered in the UK, and with 13 sites for manufacturing and drug development services located across France, Spain and Sweden. The company is backed by Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle-market private equity firm specialising in the industrial and healthcare sectors.

Providing specialist expertise in sterile multidose, lyophilization, sachets and stick packs, and development services, the firm supports drug development from concept through to commercialisation, alongside OSD, semi solid dosage manufacturing services.